GlassScriptPhysician profile
Julian N Anthony
NPI 1841392552
$2,007.48
in general payments reported to CMS, 2019-2025
38 companies · $66.66 in 2025
The $66.66 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $438 · 2021: $37.31 · 2022: $282 · 2023: $239 · 2024: $329 · 2025: $66.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $295.78 | 2019-2024 | Rezum Generator |
| Intuitive Surgical, INC. | $287.34 | 2019-2023 | |
| Laborie Medical Technologies Corp. | $188.29 | 2020-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Amgen INC. | $166.11 | 2019-2020 | |
| Cook Medical LLC | $110.82 | 2024 | Litho 150 |
| Abbvie INC. | $101.65 | 2022-2024 | Botox |
| C. R. Bard, INC. & Subsidiaries | $97.65 | 2022-2024 | Bard Urinary Drainage Bag |
| Endo Pharmaceuticals INC. | $60.39 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $57.04 | 2019 | |
| Rochester Medical Corporation | $47.46 | 2022 | |
| Astellas Pharma US INC | $45.79 | 2019-2020 | |
| Janssen Biotech, INC. | $37.21 | 2019-2023 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $35.82 | 2019 | |
| Convatec INC. | $33.35 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $30.71 | 2025 | Adstiladrin |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $29.55 | 2019 | |
| Sumitomo Pharma America, INC. | $25.30 | 2024 | Gemtesa |
| Incyte Corporation | $23.64 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.67 | 2020 | |
| Ethicon US, LLC | $22.33 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.11 | 2019 | |
| Procept Biorobotics Corporation | $21.11 | 2023 | Aquabeam Robotic System |
| Genzyme Corporation | $20.66 | 2019 | |
| Immunitybio, INC. | $20.51 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $19.26 | 2019 | |
| Urogen Pharma, INC. | $18.43 | 2022 | |
| 180 Medical, INC. | $16.78 | 2019 | |
| Photocure INC | $16.13 | 2024 | Cysview |
| Ipsen Biopharmaceuticals, INC | $14.61 | 2019 | |
| Celgene Corporation | $14.19 | 2019 | |
| Emd Serono, INC. | $14.14 | 2019 | |
| Teleflex LLC | $13.75 | 2019 | |
| Srs Medical Systems, INC. | $13.64 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $13.47 | 2019 | |
| Exelixis INC. | $13.28 | 2019 | |
| Rigel Pharmaceuticals, INC. | $13.03 | 2019 | |
| Daiichi Sankyo INC. | $12.50 | 2019 | |
| Merck Sharp & Dohme LLC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julian Anthony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.